z-logo
open-access-imgOpen Access
miR-16-2* Interferes with WNT5A to Regulate Osteogenesis of Mesenchymal Stem Cells
Author(s) -
Lijun Duan,
He Zhao,
Yang Xiong,
Xiangsheng Tang,
Yongdong Yang,
Zhenguo Hu,
Chuanhong Li,
Sixue Chen,
Xing Yu
Publication year - 2018
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000495489
Subject(s) - osteoblast , mesenchymal stem cell , osteoporosis , wnt signaling pathway , cancer research , stem cell , microrna , bone remodeling , downregulation and upregulation , chemistry , microbiology and biotechnology , endocrinology , medicine , biology , signal transduction , gene , biochemistry , in vitro
Osteoporosis is a bone metabolic disease characterized by a systemic impairment of bone mass, which results in increased propensity of fragility fractures. A reduction in the differentiation of MSCs into osteoblasts contributes to the impaired bone formation observed in osteoporosis. Mesenchymal stem cells (MSCs) are induced to differentiate into preosteoblasts, which are regulated by the signaling cascades initiated by the various signals, including miRNAs. miR-16-2* is a newly discovered miRNA that participates in diagnosis and prognosis of hepatocellular carcinoma, cervical cancer and chronic lymphocytic leukemia. However, the effect of miR-16-2* on the regulation of osteoblast differentiation and the mechanism responsible are still unclear. Here we discuss the contribution of miR-16-2* to osteoporosis, osteoblast differentiation and mineralization.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom